Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
32.34%Capital Expenditures Margin
VS
Market
Sector
Industry
History
$ 6.27Close
$ 4.28 - $ 12.48 52-Week Range
Ticker Information
Ticker
VIRCompany Name
VIR BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQVIR BIOTECHNOLOGY INC - Capital Expenditures Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VIR - CapEx % Historical data
| Date | Capital Expenditure | Capital Expenditures Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 6.14M | 32.34% | $ 19M |
| 3/31/2025 | $ 3.94M | 18.88% | $ 20.86M |
| 12/31/2024 | $ 3.93M | 5.29% | $ 74.2M |
| 9/30/2024 | $ 5.51M | 7.01% | $ 78.62M |
| 6/30/2024 | $ 6.88M | 8.72% | $ 78.88M |
| 3/31/2024 | $ 16.05M | 20.16% | $ 79.6M |
| 12/31/2023 | $ 21.57M | 25.03% | $ 86.18M |
| 9/30/2023 | $ 32.63M | 27.47% | $ 118.8M |
| 6/30/2023 | $ 47.9M | 9.76% | $ 490.72M |
| 3/31/2023 | $ 59.04M | 13.23% | $ 446.3M |
Key Performance Insights, Last 5 Years
- VIR BIOTECHNOLOGY INC's latest trailing twelve months (TTM) CapEx % stands at 7.5%.
- Over the past 5 years, VIR BIOTECHNOLOGY INC's average CapEx % has been 10.65%.
- The median CapEx % for VIR BIOTECHNOLOGY INC during this period was 7.82%
- VIR BIOTECHNOLOGY INC reached its highest CapEx % over the past 5 years at 32.34%.
- The lowest CapEx % recorded by VIR BIOTECHNOLOGY INC in the same timeframe 1.59%
VIR BIOTECHNOLOGY INC's CapEx % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx % Benchmarks
Similar metrics to Revenues:
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditure - [Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
Definition of Capital Expenditures Margin
[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].CapEx / Revenues
(=) CapEx % CapEx % for VIR BIOTECHNOLOGY INC is calculated as follows: CapEx [ $ 5.67M ] / Revenues [ $ 75.61M ]
(=) CapEx % [ 7.5% ] VIR - Capital Expenditures Margin, Last 5 years
1.59%
Minimum
Mar 31, 2022
32.34%
Maximum
Jun 30, 2025
10.65%
Average
7.82%
Median
CapEx % Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
| filtered constituents | 2.85K |
|---|---|
| min | 0% |
| max | 15.04% |
| average | 3.46% |
| median | 2.43% |
| std | 3.27% |